Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Analysis
  4. Volume 20, Issue 8
  5. Article
Volume 20, Issue 8
  • ISSN: 1573-4129
  • E-ISSN: 1875-676X

Abstract

Background

The release test (IVRT) is a tool to measure the amount and the release rate of active pharmaceutical compounds released from topical semisolid dosage forms. The IVRT provides significant information for product performance assessment and evaluation. It is also used to assess the bioequivalence study (biowaivers) for topical semisolid products.

Objective

The study aims to develop and validate the IVRT method for qualitative and quantitative estimation of ganciclovir topical products and to demonstrate the similarity between the marketed reference product and the in-house test product of ganciclovir ophthalmic gel.

Methods

The method was developed using a vertical diffusion cell with a synthetic cellulose membrane, simulated tear fluid as the receiver media, and UV detection. The IVRT study was performed at 100rpm and 32℃ for 6hr. The marketed formulation containing 0.15%w/w ganciclovir was used as a reference.

Results

The in-house test product of ganciclovir met all characterization criteria. The analytical method was optimized and validated with a concentration range of 2-14μg/ml and a regression coefficient of 0.9997 as per the ICH guideline. The developed IVRT method was simple, economical, linear, robust, reproducible, sensitive, specific, and selective to evaluate the drug release from the formulation. The %recovery at 6hr was found to be 84.43% and 78.68% for reference and test product of ganciclovir ophthalmic gel with correlation coefficient R2 0.9947 and 0.9921, respectively, this value justified the biowaivers between the reference and test formulation.

Conclusion

This method can be utilized to check topical semisolid product quality, product performance, and product uniformity. Additionally, it can also be used to waive the requirement for bioequivalency studies for ganciclovir ophthalmic gel.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpa/10.2174/0115734129322233241021110123
2024-10-23
2025-04-02

  • From This Site

    /content/journals/cpa/10.2174/0115734129322233241021110123
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. UedaC.T. ShahV.P. DerdzinskiK. EwingG. FlynnG. MaibachH. MarquesM. RyttingH. ShawS. ThakkerK. YacobiA. Topical and transdermal drug products.Pharmacopeial Forum2009353750764
     [Google Scholar]
  2. WaltersK.A. BrainK.R. Topical and transdermal delivery.Pharmaceutical Preformulation and FormulationCRC press2016487538
     [Google Scholar]
  3. OsborneD.W. AmannA.H. Topical Drug Delivery Formulations. Drugs and the Pharmaceutical Sciences.CRC PressBoca Raton198917517810.1201/9780367803933
     [Google Scholar]
  4. KanferI. RathS. PuraziP. MudyahotoN.A. In vitro release testing of semi-solid dosage forms.Dissolut. Technol.2017243526010.14227/DT240317P52
     [Google Scholar]
  5. ShahV.P. In vitro release from semisolid dosage forms - What is its value?.Percutaneous Absorption BronaughR.L. MaibachH.I. Boca RatonTaylor & Francis Group20054th ed47348010.1201/9780849359033.ch34
     [Google Scholar]
  6. SUPAC-SS: Nonsterile semisolid dosage forms; scale-up and post-approval changes: Chemistry, manufacturing and controls; in vitro release testing and in vivo bioequivalence documentation.Available from: https://www.fda.gov/media/71141/download 1997
  7. ThakkerK. Summary report on workshop on in vitro release test (IVRT) and In vitro permeation test (IVPT) methods.Dissolut. Technol.2021284505210.14227/DT280421P450
     [Google Scholar]
  8. DandamudiS. In vitro bioequivalence data for a topical product: Bioequivalence review perspective.Available from: https://www.fda.gov/media/110389/download 2017
  9. SiewertM. DressmanJ. BrownC.K. ShahV.P. AiacheJ.M. AoyagiN. BashawD. BrownC. BrownW. BurgessD. CrisonJ. DeLucaP. DjerkiR. DressmanJ. FosterT. GjellanK. GrayV. HussainA. IngallineraT. KlanckeJ. KraemerJ. KristensenH. KumiK. LeunerC. LimbergJ. LoosP. MargulisL. MarroumP. MoellerH. MuellerB. Mueller-ZsigmondyM. OkafoN. OuderkirkL. ParsiS. QureshiS. RobinsonJ. ShahV. SiewertM. UppoorR. WilliamsR. FIP/AAPS guidelines to dissolution/In vitro release testing of novel/special dosage forms.AAPS PharmSciTech200341E710.1208/pt04010712916916
     [Google Scholar]
  10. Draft guideline on quality and equivalence of topical products.Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-and-equivalence-topical-products_en.pdf 2018
  11. OlejnikA. GoscianskaJ. NowakI. Active compounds release from semisolid dosage forms.J. Pharm. Sci.2012101114032404510.1002/jps.2328922886492
     [Google Scholar]
  12. KleinR.R. HeckartJ.L. ThakkerK.D. In vitro release testing methodology and variability with the vertical diffusion cell (VDC).Dissolut. Technol.2018253526110.14227/DT250318P52
     [Google Scholar]
  13. Semisolid drug products - Performance tests.Available from: https://doi.usp.org/USPNF/USPNF_M5695_01_01.html
  14. In vitro release test studies for topical drug products submitted in ANDAs.Available from: https://www.fda.gov/media/162476/download 2022
  15. TiffnerK.I. KanferI. AugustinT. RamlR. RaneyS.G. SinnerF. A comprehensive approach to qualify and validate the essential parameters of an In vitro release test (IVRT) method for acyclovir cream, 5.Int. J. Pharm.20185351-221722710.1016/j.ijpharm.2017.09.04928935255
     [Google Scholar]
  16. ModiP.B. ShahN.J. Optimization of an in vitro release test for topical formulations containing eberconazole nitrate and mometasone furoate.Pharma Chem.20157819
     [Google Scholar]
  17. RathS. KanferI. A validated IVRT method to assess topical creams containing metronidazole using a novel approach.Pharmaceutics202012211910.3390/pharmaceutics1202011932028557
     [Google Scholar]
  18. RamanahA. KhamangaS.M. WalkerR.B. Development and validation of an in vitro release test for ketoconazole (KZ) on semi-solid dosage forms.Available from: https://www.researchgate.net/publication/268806345_Development_and_Validation_of_an_in_vitro_Release_Test_for_Ketoconazole_KZ_on_semi-solid_Dosage_Forms 2014
  19. BezuglayaE. LiapunovaA. ZinchenkoI. LyapunovN. Study of factors affecting the in vitro release of dexpanthenol from solutions and topical semi-solid preparations. ScienceRise.Pharm. Sci.20233 (43)415
     [Google Scholar]
  20. BaoQ. ShenJ. JogR. ZhangC. NewmanB. WangY. ChoiS. BurgessD.J. In vitro release testing method development for ophthalmic ointments.Int. J. Pharm.20175261-214515610.1016/j.ijpharm.2017.04.07528461266
     [Google Scholar]
  21. GuptaPK. PancholiSS. DasP. In Vitro Drug Release Testing Method for Nepafenac Ophthalmic Suspension.Journal of Pharmaceutical Sciences2024 Apr 1113410617
     [Google Scholar]
  22. MudyahotoN.A. RathS. RamanahA. KanferI. In vitro release resting (IVRT) of topical hydrocortisone acetate creams: A novel approach using positive and negative controls.Dissolut. Technol.202027161210.14227/DT270120P6
     [Google Scholar]
  23. KleinR.R. TaoJ.Q. WilderS. BurchettK. BuiQ. ThakkerK.D. Development of an in vitro release test (IVRT) for a vaginal microbicide gel.Dissolut. Technol.201017461010.14227/DT170410P6
     [Google Scholar]
  24. HicranG.D. EcemK.Ş. CerenO.G. BanuÖ.A. MineU.G. Method development and validation of in vitro release test for fluorometholone ophthalmic suspension using franz diffusion cell system.Glob J Pharmaceu Sci.202192555758
     [Google Scholar]
  25. ManianM. JainP. VoraD. BangaA.K. Formulation and evaluation of the in vitro performance of topical dermatological products containing diclofenac sodium.Pharmaceutics2022149189210.3390/pharmaceutics1409189236145640
     [Google Scholar]
  26. CetinD. TurkerT.G. YilmazN. KarakoyB.A. Comparative in vitro release test using franz diffusion cell for luliconazole % 1 cream with reference drug product.Available from: https://www.labmate-online.com/article/chromatography/1/bilim-pharmaceuticals/comparative-in-vitro-release-test-using-franz-diffusion-cell-for-luliconazole-1-cream-with-reference-drug-product/3019 2022
  27. BezuglayaE. IvashchenkoH. LyapunovN. ZinchenkoI. LiapunovaA. StolperY. LiapunovO. PukhovaT. Study of factors affecting the in vitro release of diclofenac sodium from hypromelose-based gels. ScienceRise.Pharm. Sci.20215331231
     [Google Scholar]
  28. PippallaS. NekkalapudiA.R. JillellamudiS.B. ReddyM.P. KumarC.V. A stability-indicating, reversed-phase HPLC method for quantification of assay and organic impurities in doxycycline hyclate bulk and parenteral dosage forms.Biomed. Chromatogr.2023376e562610.1002/bmc.562636930874
     [Google Scholar]
  29. ZafarA. AlsaidanO.A. ImamS.S. YasirM. AlharbiK.S. KhalidM. Formulation and evaluation of moxifloxacin loaded bilosomes in-situ gel: Optimization to antibacterial evaluation.Gels20228741810.3390/gels807041835877503
     [Google Scholar]
  30. KhanN. AqilM. ImamS.S. AliA. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: In vitro and ex vivo characterization.Pharm. Dev. Technol.201520666266910.3109/10837450.2014.91080724754411
     [Google Scholar]
  31. ImamS.S. GilaniS.J. ZafarA. JumahM.N.B. AlshehriS. Formulation of miconazole-loaded chitosan–carbopol vesicular gel: optimization to in vitro characterization, irritation, and antifungal assessment.Pharmaceutics202315258110.3390/pharmaceutics1502058136839903
     [Google Scholar]
  32. ZafarA. YasirM. SinghL. JafarM. WarsiM.H. PandaD.S. Luteolin-loaded invasomes gel for transdermal delivery: Development, optimization, in-vitro, and preclinical evaluation.J. Oleo Sci.20247391221124010.5650/jos.ess2404139218639
     [Google Scholar]
/content/journals/cpa/10.2174/0115734129322233241021110123
Loading
Development and Validation of In-Vitro Release Test (IVRT) Method for Topical Complex Generic - Ganciclovir Ophthalmic Gel
Current Pharmaceutical Analysis 20, 932 (2024); https://doi.org/10.2174/0115734129322233241021110123
/content/journals/cpa/10.2174/0115734129322233241021110123
/content/journals/cpa/10.2174/0115734129322233241021110123
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): biowaiver; ganciclovir; in-house formulation; In-vitro release test(IVRT); method development and validation; ophthalmic gel; topical formulation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test